Skip to main content

Table 5 Outcomes during the follow-up

From: Vasodilator-stimulated phosphoprotein-guided Clopidogrel maintenance therapy reduces cardiovascular events in atrial fibrillation patients requiring anticoagulation therapy and scheduled for percutaneous coronary intervention: a prospective cohort study

Outcomes

VASP-guided group

Control group

P-value

n = 241

n = 240

Cardiovascular death

1(0.4)

2(0.8)

0.34

MI

1(0.4)

2 (0.8)

0.34

TVR

1(0.4)

3(1.3)

0.03

Stent thrombosis

1(0.4)

1(0.4)

0.21

Systemic embolism

1(0.4)

2(0.8)

0.34

Stroke

1(0.4)

2(0.8)

0.34

All MACCE

6(2.5)

12(5.0)

0.02

TIMI major bleeding

7(3.0)

6(2.8)

0.72

TIMI minor bleeding

37(15.3)

23(9.7)

0.03

  1. Values are presented as n(%)
  2. MACCE major adverse cardiovascular and cerebral event, MI myocardial infarction, TIMI thrombolysis in myocardial infarction, TVR target vessel revascularisation